Evidence map›Paper›PMID 35738594›Full record

ReviewIn vivo (Athens, Greece)

Axillary Lymph Node Swelling After COVID-19 Booster Vaccination: Japanese Case Report and Literature Review.

Nobuyasu Yoshimoto, Akemi Yanagi, Satoru Takayama, Masaki Sakamoto, Keisuke Tomoda, Ken Ishikawa, Akifumi Kawate, Shoryu Takayama, Masakatsu Yamashita, Shinya Yamamoto and 3 more

Open access · diamondAbstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Nobuyasu YoshimotoDepartment of Breast Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan; paris@s4.dion.ne.jp.
Akemi YanagiDepartment of Radiology, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Satoru TakayamaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Masaki SakamotoDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Keisuke TomodaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Ken IshikawaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Akifumi KawateDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Shoryu TakayamaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Masakatsu YamashitaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Shinya YamamotoDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Kioto YokoyamaDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Hiroto SuzukiDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Hisanori KaniDepartment of Surgery, Nagoya Tokushukai General Hospital, Kasugai, Japan.
Yao Tokushukai General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCOVID-19 has been a global pandemic for more than 2 years, and vaccination against COVID-19 using an mRNA vaccine is widespread. The COVID-19 vaccination can cause specific side-effects, such as axillary lymph node swelling; therefore, breast oncologists should pay attention to such occurrences. Initially, only two COVID-19 vaccinations were planned; however, in some countries third or fourth vaccines have been administered. Here, we present a female case who developed axillary lymph node swelling after her third vaccination. We have also reviewed the literature regarding this side-effect after a third or fourth COVID-19 vaccination. CASE REPORT: A 64-year-old woman who came to our clinic regarding a mammography abnormality in her left breast. She had no palpable mass, but a left breast mass was shown by mammography, and ultrasonography and magnetic resonance imaging indicated a hamartoma. At 2 months after her second COVID-19 vaccination when she underwent these tests, she had no axillary lymph node swelling. We planned a follow-up after 6 months. At her next visit, by chance, she underwent ultrasonography 14 days after she received a third COVID-19 vaccination, and a swollen axillary lymph node was observed.

conclusionAxillary lymph node swelling can occur after a third COVID-19 vaccination. Therefore, breast oncologists will have to consider this side-effect of COVID-19 vaccination when diagnosing breast tumors.

Indexed as

Breast NeoplasmsCOVID-19AxillaCOVID-19 VaccinesFemaleHumansJapanLymphatic MetastasisLymph NodesMiddle AgedmRNA VaccinesVaccinationVaccines, SyntheticCOVID-19 VaccinesmRNA VaccinesVaccines, Syntheticaxillary lymph node swellingCOVID-19 booster vaccineside-effect

Identifiers

PMID35738594
PMCPMC9301409
OpenAlexW4283452640

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.